Federated Hermes, Inc. Next Cure, Inc. Transaction History

Federated Hermes, Inc.

$43 Billion
Q4 2024

A detailed history of Federated Hermes, Inc. transactions in Next Cure, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 315,180 shares of NXTC stock, worth $236,385. This represents 0.0% of its overall portfolio holdings.

Number of Shares

315,180

Previous 321,527 1.97%

Holding current value

$236,385

Previous $440,000 45.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$0.77 - $1.54 $4,887 - $9,774	-6,347 Reduced 1.97%	315,180 $242,000
Q3 2024 Nov 13, 2024	SELL	$1.33 - $1.78 $7,817 - $10,462	-5,878 Reduced 1.8%	321,527 $440,000
Q1 2024 May 14, 2024	SELL	$1.13 - $2.23 $499 - $985	-442 Reduced 0.13%	327,405 $730,000
Q4 2023 Jan 31, 2024	SELL	$1.03 - $1.45 $40,148 - $56,519	-38,979 Reduced 10.63%	327,847 $373,000
Q3 2023 Nov 13, 2023	SELL	$1.29 - $1.84 $158 - $226	-123 Reduced 0.03%	366,826 $473,000
Q2 2023 Aug 14, 2023	SELL	$1.47 - $1.86 $31,781 - $40,213	-21,620 Reduced 5.56%	366,949 $660,000
Q1 2023 May 08, 2023	SELL	$1.46 - $1.83 $658 - $825	-451 Reduced 0.12%	388,569 $575,000
Q4 2022 Feb 13, 2023	SELL	$1.2 - $3.07 $163,663 - $418,705	-136,386 Reduced 25.96%	389,020 $548,000
Q3 2022 Nov 14, 2022	BUY	$2.72 - $5.19 $193 - $368	71 Added 0.01%	525,406 $1.45 Million
Q2 2022 Aug 15, 2022	SELL	$3.38 - $5.27 $801 - $1,248	-237 Reduced 0.05%	525,335 $2.47 Million
Q1 2022 May 13, 2022	BUY	$4.76 - $6.24 $152 - $199	32 Added 0.01%	525,572 $2.55 Million
Q4 2021 Feb 14, 2022	SELL	$5.7 - $9.1 $8,236 - $13,149	-1,445 Reduced 0.27%	525,540 $3.15 Million
Q3 2021 Nov 15, 2021	BUY	$6.74 - $8.02 $112,571 - $133,950	16,702 Added 3.27%	526,985 $3.55 Million
Q2 2021 Aug 16, 2021	BUY	$7.6 - $10.28 $3.88 Million - $5.25 Million	510,283 New	510,283 $4.1 Million
Q1 2021 May 13, 2021	SELL	$9.81 - $13.88 $30,293 - $42,861	-3,088 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$9.47 - $12.43 $28,476 - $37,377	3,007 Added 3712.35%	3,088 $34,000
Q3 2020 Nov 12, 2020	SELL	$8.15 - $21.17 $909,523 - $2.36 Million	-111,598 Reduced 99.93%	81 $1,000
Q2 2020 Aug 13, 2020	BUY	$21.19 - $40.2 $2.37 Million - $4.49 Million	111,679 New	111,679 $2.39 Million

Others Institutions Holding NXTC

# of Institutions

Shares Held

14.6M

Call Options Held

Put Options Held

View Full List

About NextCure, Inc.

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $20.8M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

More about NXTC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Next Cure, Inc. Transaction History